![](/img/cover-not-exists.png)
Pretreatment SUV max may influence the clinical benefit of BR over R-CHOP in patients with previously untreated FL
Strati, Paolo, Ahmed, Mohamed Amin, Nastoupil, Loretta J., Feng, Lei, Hagemeister, Fredrick B., Fayad, Luis E., Rodriguez, Maria A., Samaniego, Felipe, Wang, Michael, Westin, Jason R., Lee, Hun J., IyJournal:
Leukemia & Lymphoma
DOI:
10.1080/10428194.2020.1716221
Date:
January, 2020
File:
PDF, 1.61 MB
2020